Disease management
The San Francisco-based musculoskeletal care platform will be included in Cigna’s offerings for self-insured employers.
The company's patch uses intradermal electrochemical sensors to monitor glucose levels and provide metabolic insights to individuals with type 2 diabetes not on insulin.
The partnership will focus on building AI tools that accelerate heart disease and cancer detection with the aim of reducing diagnostic turnaround times.
Also, an AI-powered breath test for diagnosing silicosis has been developed in Sydney.
Also, Cureskin from India has launched an AI-powered hair analysis feature on its mobile application.
The research initiative aims to enhance the Galaxy Watch’s sleep apnea detection feature and ultimately create AI-powered tools for proactive sleep health management.
The California-based company will use the funds to expand its healthcare advocate network nationwide and accelerate its development.
Musk says the implant will initially provide blind individuals with low-resolution sight with the potential for superhuman vision in the future.
Trace will use Unlearn's digital twin generator for ALS to create digital twins of clinical trial participants to advance ALS research.
The company's SimpleSense wearable will ingest glucose data from the Dexcom G7 continuous glucose monitor system.